These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4122307)

  • 1. Prevalence of the group-specific (gs) antigen and infectious virus expressions of the murine C-type RNA viruses during the life span of BALB-cCr mice.
    Peters RL; Hartley JW; Spahn GJ; Rabstein LS; Whitmire CE; Turner HC; Huebner RJ
    Int J Cancer; 1972 Sep; 10(2):283-9. PubMed ID: 4122307
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidence of group-specific (gs) antigens of type C tumor viruses in spontaneous neoplasms of BALB-cCr mice.
    Peters RL; Spahn GJ; Rabstein LS; Turner HC; Huebner RJ
    Int J Cancer; 1972 Sep; 10(2):290-5. PubMed ID: 4122308
    [No Abstract]   [Full Text] [Related]  

  • 3. Murine leukemia and sarcoma viruses: further studies on the antigens of the viral envelope.
    Gomard E; Leclerc JC; Levy JP
    J Natl Cancer Inst; 1973 Apr; 50(4):955-61. PubMed ID: 4122212
    [No Abstract]   [Full Text] [Related]  

  • 4. Natural expression of feline type-C virus genomes, prevalence of detectable felv and RD-114 GS antigen, type-C particles and infectious virus in postnatal and fetal cats.
    Gardner MB; Rasheed S; Rongey RW; Charman HP; Alena B; Gilden RV; Huebner RJ
    Int J Cancer; 1974 Jul; 14(1):97-105. PubMed ID: 4142463
    [No Abstract]   [Full Text] [Related]  

  • 5. Group- and type-specific antigens in mouse leukaemia induced by Friend, Mazurenko and Rauscher viruses.
    Mazurenko NP; Gurtsevich VE
    Neoplasma; 1972; 19(4):277-82. PubMed ID: 4341019
    [No Abstract]   [Full Text] [Related]  

  • 6. Relationship of virulent and attenuated RNA oncogenic virus antigens to surface antigens of the virus-transformed cell: implications for the reverse transcriptase system, the provirus, protovirus and oncogene theories of neoplasia, and the immunoprophylaxis of RNA virus-induced tumors.
    Cohen MH
    J Surg Oncol; 1974; 6(5):423-40. PubMed ID: 4427461
    [No Abstract]   [Full Text] [Related]  

  • 7. Distinction between envelope antigens of murine xenotropic and ecotropic type C viruses by immunoelectron microscopy.
    Oshiro LS; Levy JA; Riggs JL; Lennette EH
    J Gen Virol; 1977 May; 35(2):317-23. PubMed ID: 69013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunity to murine sarcoma virus induced tumours. IV. Direct cellular cytolysis of 51Cr labelled target cells in vitro and analysis of blocking factors which modulate cytotoxicity.
    Gorczynski RM; Knight RA
    Br J Cancer; 1975 Apr; 31(4):387-404. PubMed ID: 50851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host-gene control of type-C RNA tumor virus expression and tumorigenesis in inbred mice.
    Meier H; Taylor BA; Cherry M; Buebner RJ
    Proc Natl Acad Sci U S A; 1973 May; 70(5):1450-5. PubMed ID: 4351180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rejection of non viral tumors caused by infection with murine sarcoma virus].
    Basombrio MA
    Medicina (B Aires); 1977; 37(2):127-32. PubMed ID: 197370
    [No Abstract]   [Full Text] [Related]  

  • 11. Antigenic properties of endogenous type-C viruses from spontaneously transformed clones of BALB-3T3.
    Aoki T; Todaro GJ
    Proc Natl Acad Sci U S A; 1973 May; 70(5):1598-602. PubMed ID: 4351184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA tumor virus gs antigen and tumor induction by various doses of 3-methylcholanthrene in various strains of mice treated as weanlings.
    Whitmire CE; Salerno RA
    Cancer Res; 1972 Jun; 32(6):1129-32. PubMed ID: 4337883
    [No Abstract]   [Full Text] [Related]  

  • 13. Autogenous immunity to endogenous RNA tumor virus antigens in mice with a low natural incidence of lymphoma.
    Hanna MG; Tennant RW; Yuhas JM; Clapp NK; Batzing BL; Snodgrass MJ
    Cancer Res; 1972 Oct; 32(10):2226-34. PubMed ID: 4117035
    [No Abstract]   [Full Text] [Related]  

  • 14. Naturally occurring sarcoma virus of the BALB/cCr mouse.
    Peters RL; Rabstein LS; VanVleck R; Kelloff GJ; Huebner RJ
    J Natl Cancer Inst; 1974 Dec; 53(6):1725-9. PubMed ID: 4373578
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial: Murine type-C RNA viruses: a proposed reclassification, other possible pathogenicities, and a new immunologic function.
    Aoki T
    J Natl Cancer Inst; 1974 Apr; 52(4):1029-34. PubMed ID: 4133197
    [No Abstract]   [Full Text] [Related]  

  • 16. Specificity of 51Cr-release cytotoxicity of lymphocytes immune to murine sarcoma virus.
    Herberman RB; Aoki T; Nunn M; Lavrin DH; Soares N; Gazdar A; Holden H; Chang KS
    J Natl Cancer Inst; 1974 Oct; 53(4):1103-11. PubMed ID: 4139276
    [No Abstract]   [Full Text] [Related]  

  • 17. Demonstration of a cell-surface antigen associated with murine sarcoma virus by immunoelectron microscopy.
    Aoki T; Stephenson JR; Aaronson SA
    Proc Natl Acad Sci U S A; 1973 Mar; 70(3):742-6. PubMed ID: 4351802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine sarcoma virus pseudotypes used as immunogens against viral and chemical oncogenesis.
    Basombrío MA; Mayer AM; Pasqualini CD
    Cancer Res; 1977 Jun; 37(6):1768-76. PubMed ID: 192461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [About the heterogeneity of the murine oncornavirus group-specific antigen gs-1 (author's transl)].
    Denner J; Dorfman NA
    Arch Geschwulstforsch; 1976; 46(3):176-82. PubMed ID: 61741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of type-C viruses from the Asian feral mouse Mus musculus molossinus.
    Lieber M; Sherr C; Potter M; Todaro G
    Int J Cancer; 1975 Feb; 15(2):211-20. PubMed ID: 47844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.